Breaking News Instant updates and real-time market news.

MDT

Medtronic

$111.10

-0.15 (-0.13%)

17:47
11/19/19
11/19
17:47
11/19/19
17:47

Medtronic price target raised to $125 from $120 at Piper Jaffray

Piper Jaffray analyst Matt O'Brien raised his price target on Medtronic to $125 and kept his Overweight rating after its Q4 earnings beat and raised FY20 guidance. The analyst says the company's Restorative Therapies Group saw a "robust" 6% revenue growth, with Mazor driving increased market share along with above-market growth rate in Implants. O'Brien adds that a number of Medtronic's "exciting new products" should allow the company to accelerate revenue growth in the second half of FY20 and into FY21.

  • 19

    Nov

MDT Medtronic
$111.10

-0.15 (-0.13%)

09/25/19
GUGG
09/25/19
NO CHANGE
GUGG
Neutral
Medtronic financial projections for Hugo robot 'underwhelming,' says Guggenheim
After attending Medtronic's (MDT) "much-anticipated" robotic-assisted surgery event, where the company gave a first look at the Hugo RAS system, Guggenheim analyst Chris Pasquale noted that the company gave an update on regulatory timelines and initial revenue targets, though information on pricing and clinical comparability to Intuitive Surgical's (ISRG) da Vinci system were "notably absent." He was impressed by certain design elements, though he thinks management's financial projections for Hugo were "somewhat underwhelming," said Pasquale, who keeps a Neutral rating on Medtronic shares.
09/27/19
PIPR
09/27/19
NO CHANGE
PIPR
Piper says insulin pump survey most positive for Insulet
Piper Jaffray analyst JP McKim conducted an insulin delivery survey in August and found that pump penetration is going "much higher" both in type 1s and in type 2s. The growth in the type 2 market is underappreciated by investors and will largely benefit Insulet (PODD) today given the pharmacy channel increases that access, McKim tells investors in a research note. Further, survey indicated that Medtronic (MDT) is expected to lose between 1,100-1,300 basis points of market share with Tandem Diabetes (TNDM) being the greatest beneficiary with the biggest uptick forecast in 2020, says the analyst. McKim views the insulin pump survey as most positive for Insulet.
11/01/19
PIPR
11/01/19
INITIATION
Target $39
PIPR
Overweight
Axonics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Adam Maeder initiated coverage of Axonics Modulation Technologies (AXNX) with an Overweight rating and $39 price target. Although there is some investor disappointment that U.S. launch didn't commence sooner and urinary approval is still pending, Axonics remains positioned for commercial success and "strong" sales growth next year, Maeder tells investors in a research note. He believes the company's r-SNM has meaningful advantages over Medtronic's (MDT) InterStim II product and sees "plenty of room in the market for a second competitor."
11/05/19
PIPR
11/05/19
NO CHANGE
PIPR
Overweight
Medtronic filed patent lawsuit against Axonics, says Piper Jaffray
Piper Jaffray analyst Adam Maeder says Medtronic (MDT) yesterday filed a lawsuit with the U.S. District Court for the Central District of California alleging that Axonics Modulation Technologies' rechargeable sacral neuromodulation system infringes its U.S. patents. As part of the lawsuit, Medtronic is seeking injunctive relief and damages for alleged intellectual property infringement, the analyst points out. The timing of the lawsuit coincides with Axonics' U.S. commercial launch, says Maeder, who points out that patent litigation is not uncommon in the medical device sector and generally takes a while to play out. He expects Axonics to "defend itself vigorously and continue to sell r-SNM throughout the ongoing legal process."

TODAY'S FREE FLY STORIES

09:05
12/09/19
12/09
09:05
12/09/19
09:05
General news
U.S. equities are mildly weaker »

U.S. equities are mildly…

AMGN

Amgen

$233.74

0.3 (0.13%)

09:04
12/09/19
12/09
09:04
12/09/19
09:04
Hot Stocks
Amgen signs lease for new R&D facility in San Francisco »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$9.67

0.15 (1.58%)

, MRK

Merck

$88.84

0.09 (0.10%)

09:03
12/09/19
12/09
09:03
12/09/19
09:03
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: ArQule (ARQL), up…

ARQL

ArQule

$9.67

0.15 (1.58%)

MRK

Merck

$88.84

0.09 (0.10%)

THOR

Synthorx

$24.98

-0.02 (-0.08%)

SNY

Sanofi

$46.05

-0.04 (-0.09%)

PCG

PG&E

$9.65

-0.13 (-1.33%)

SWKS

Skyworks

$101.40

1.42 (1.42%)

QRVO

Qorvo

$106.68

0.96 (0.91%)

THO

Thor Industries

$67.76

2.17 (3.31%)

DPLO

Diplomat Pharmacy

$5.82

0.22 (3.93%)

UNH

UnitedHealth

$280.18

0.34 (0.12%)

M

Macy's

$15.15

0.04 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

  • 13

    Dec

  • 07

    Jan

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

SGBX

SG Blocks

$0.25

-0.0104 (-3.98%)

09:03
12/09/19
12/09
09:03
12/09/19
09:03
Hot Stocks
SG Blocks awarded new contract for food and beverage venue »

SG Blocks announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNR

Pentair

$44.80

0.335 (0.75%)

09:03
12/09/19
12/09
09:03
12/09/19
09:03
Upgrade
Pentair rating change  »

Pentair upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AOS

A.O. Smith

$46.76

-0.13 (-0.28%)

, PNR

Pentair

$44.80

0.335 (0.75%)

09:01
12/09/19
12/09
09:01
12/09/19
09:01
Downgrade
A.O. Smith, Pentair rating change  »

A.O. Smith downgraded to…

AOS

A.O. Smith

$46.76

-0.13 (-0.28%)

PNR

Pentair

$44.80

0.335 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AUPH

Aurinia Pharmaceuticals

$15.45

0.46 (3.07%)

09:00
12/09/19
12/09
09:00
12/09/19
09:00
Syndicate
Aurinia Pharmaceuticals files to sell $150M in common stock »

Jefferies LLC and SVB…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNG

RingCentral

$166.21

1.28 (0.78%)

, AVYA

Avaya

$11.83

-0.2 (-1.66%)

08:59
12/09/19
12/09
08:59
12/09/19
08:59
Recommendations
RingCentral, Avaya analyst commentary  »

BofA raises RingCentral…

RNG

RingCentral

$166.21

1.28 (0.78%)

AVYA

Avaya

$11.83

-0.2 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

TFC

Truist Financial

$54.16

0.66 (1.23%)

08:58
12/09/19
12/09
08:58
12/09/19
08:58
Initiation
Truist Financial initiated  »

Truist Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

MA

MasterCard

$290.37

0.43 (0.15%)

08:56
12/09/19
12/09
08:56
12/09/19
08:56
Conference/Events
MasterCard management to meet with SunTrust »

Field Trip to Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

TTWO

Take-Two

$123.76

-0.14 (-0.11%)

08:56
12/09/19
12/09
08:56
12/09/19
08:56
Conference/Events
Take-Two management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

AAPL

Apple

$270.71

5.15 (1.94%)

, BAC

Bank of America

$33.67

0.57 (1.72%)

08:55
12/09/19
12/09
08:55
12/09/19
08:55
Options
Notable open interest changes for December 9th »

Friday's total…

AAPL

Apple

$270.71

5.15 (1.94%)

BAC

Bank of America

$33.67

0.57 (1.72%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

DHR

Danaher

$148.17

1.1 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 15

    Jan

  • 26

    Feb

FNMA

Fannie Mae

$0.00

(0.00%)

, FMCC

Freddie Mac

$0.00

(0.00%)

08:54
12/09/19
12/09
08:54
12/09/19
08:54
Recommendations
Fannie Mae, Freddie Mac analyst commentary  »

Odeon says ruling seems…

FNMA

Fannie Mae

$0.00

(0.00%)

FMCC

Freddie Mac

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPSN

LivePerson

$37.81

-0.62 (-1.61%)

08:54
12/09/19
12/09
08:54
12/09/19
08:54
Conference/Events
LivePerson management to meet with Benchmark »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

NNBR

NN, Inc.

$8.00

0.1 (1.27%)

08:53
12/09/19
12/09
08:53
12/09/19
08:53
Recommendations
NN, Inc. analyst commentary  »

NN, Inc. preferred…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:52
12/09/19
12/09
08:52
12/09/19
08:52
Conference/Events
Jefferies European economist to hold an analyst/industry conference call »

European Economist Owen,…

LEA

Lear

$124.81

4.05 (3.35%)

08:51
12/09/19
12/09
08:51
12/09/19
08:51
Conference/Events
Lear management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

WWD

Woodward

$122.27

2.55 (2.13%)

08:49
12/09/19
12/09
08:49
12/09/19
08:49
Recommendations
Woodward analyst commentary  »

Woodward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$20.32

0.56 (2.83%)

08:49
12/09/19
12/09
08:49
12/09/19
08:49
Conference/Events
JinkoSolar management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ABEO

Abeona Therapeutics

$3.00

0.25 (9.09%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Hot Stocks
Abeona Therapeutics cleared to initiate EB-101 Phase 3 clinical trial »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$85.02

-0.56 (-0.65%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Conference/Events
Jacobs Engineering management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DK

Delek US

$34.30

0.99 (2.97%)

, MPC

Marathon Petroleum

$60.17

0.4 (0.67%)

08:46
12/09/19
12/09
08:46
12/09/19
08:46
Downgrade
Delek US, Marathon Petroleum rating change  »

JPMorgan downgrades Delek…

DK

Delek US

$34.30

0.99 (2.97%)

MPC

Marathon Petroleum

$60.17

0.4 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZUN

Baozun

$35.29

-0.06 (-0.17%)

, AIMT

Aimmune

$29.67

0.51 (1.75%)

08:45
12/09/19
12/09
08:45
12/09/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BZUN

Baozun

$35.29

-0.06 (-0.17%)

AIMT

Aimmune

$29.67

0.51 (1.75%)

MED

Medifast

$90.67

0.48 (0.53%)

CGC

Canopy Growth

$18.65

0.07 (0.38%)

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$15.11

-0.8 (-5.03%)

SCO

Scor ADR

$13.14

-0.3 (-2.23%)

BRFS

BRF S.A.

$8.87

0.22 (2.54%)

ET

Energy Transfer LP

$11.50

-0.1 (-0.86%)

RVLV

Revolve Group

$16.74

-0.46 (-2.67%)

DO

Diamond Offshore

$6.01

0.44 (7.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

INFN

Infinera

$6.12

0.115 (1.92%)

08:44
12/09/19
12/09
08:44
12/09/19
08:44
Conference/Events
Infinera management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

DPLO

Diplomat Pharmacy

$5.82

0.22 (3.93%)

08:43
12/09/19
12/09
08:43
12/09/19
08:43
Downgrade
Diplomat Pharmacy rating change  »

Diplomat Pharmacy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.